Insider · CIK 0001862613
Shaun Bagai
ceoofficerdirector
Files at RNXT (RenovoRx, Inc.). First filing Apr 8, 2025, latest Dec 22, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
6 / 0
$41k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RNXT: RenovoRx, Inc.
RNXTOct 9, 2026 · close 1.28
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | RenovoRx, Inc. | $4,507 5,000 shares | +1% | +23% from low-42% from high | |
| 41Moderate | RenovoRx, Inc. | $4,262 5,000 shares | +2% | +19% from low-44% from high | |
| 33Weak | RNXTbuy RenovoRx, Inc. | $9,297 10,000 shares | +3% | +22% from low-39% from high | |
| 53Moderate | RenovoRx, Inc. | $6,821 7,500 shares | +2% | +17% from low-42% from high | |
| 63Notable | RenovoRx, Inc. | $8,300 10,000 shares | +3% | +5% from low-46% from high | |
| 58Moderate | RenovoRx, Inc. | $8,300 10,000 shares | +3% | 0% from low-49% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | RNXT RenovoRx, Inc. | POpen-market purchase Common Stockindirect: The Bagai Family Trust | +24,300 | - | - | 313,357 | Mar 24, 2026 |
| Mar 20, 2026 | RNXT RenovoRx, Inc. | POpen-market purchase Warrantsderivativeindirect: The Bagai Family Trust | +12,150 | - | - | 12,150 | Mar 24, 2026 |
| Dec 18, 2025 | RNXT RenovoRx, Inc. | POpen-market purchase Common Stock | +5,000 | $0.90 | $4,507 | 340,040 | Dec 22, 2025 |
| Dec 17, 2025 | RNXT RenovoRx, Inc. | POpen-market purchase Common Stock | +5,000 | $0.85 | $4,262 | 335,040 | Dec 19, 2025 |
| Aug 22, 2025 | RNXT RenovoRx, Inc. | POpen-market purchase Common Stock | +5,000 | $0.95 | $4,748 | 325,040 | Aug 26, 2025 |
| Aug 25, 2025 | RNXT RenovoRx, Inc. | POpen-market purchase Common Stock | +5,000 | $0.91 | $4,549 | 330,040 | Aug 26, 2025 |
| Jul 1, 2025 | RNXT RenovoRx, Inc. | AGrant or award Stock Optionderivative | +102,498 | $0.00 | $0 | 102,498 | Jul 3, 2025 |
| Apr 15, 2025 | RNXT RenovoRx, Inc. | POpen-market purchase Common Stock | +7,500 | $0.91 | $6,821 | 320,040 | Apr 16, 2025 |
| Apr 14, 2025 | RNXT RenovoRx, Inc. | AGrant or award Stock Optionderivative | +409,992 | $0.00 | $0 | 409,992 | Apr 16, 2025 |
| Apr 9, 2025 | RNXT RenovoRx, Inc. | POpen-market purchase Common Stock | +10,000 | $0.83 | $8,300 | 312,540 | Apr 10, 2025 |
| Apr 7, 2025 | RNXT RenovoRx, Inc. | POpen-market purchase Common Stock | +10,000 | $0.83 | $8,300 | 302,540 | Apr 8, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.